Noninvasive Risk Assessment Early After a Myocardial Infarction Are We Looking at the Right Indicators? by Goyal, Sandeep & Punnam, Sujeeth R.
N
A
a
A
a
E
a
i
m
W
t
t
a
w
o
t
r
a
f
k
e
o
i
a
p
m
i
v
t
t
l
t
d
S
*
*
D
A
M
E
E
R
1
Journal of the American College of Cardiology Vol. 51, No. 19, 2008
© 2008 by the American College of Cardiology Foundation ISSN 0735-1097/08/$34.00
Published by Elsevier Inc.CORRESPONDENCELetters to the Editor
2
3
R
W
T
u
E
t
w
p
T
t
0
a
1
t
l
t
n
1
p
A
n
a
1
t
r
u
b
s
6
(
p
p
o
s
d
t
a
l
a
*oninvasive Risk
ssessment Early After
Myocardial Infarction
re We Looking
t the Right Indicators?
xner et al. (1) looked at the role of combined assessment of
utonomic tone plus cardiac electrical substrate as markers of predict-
ng long-term mortality in evaluating 322 patients who survived
yocardial infarction (MI) but with left ventricular (LV) dysfunction.
e have 3 concerns about this study. First, the authors fail to report
he incidence of nonsustained ventricular tachycardia in study pa-
ients. Nonsustained ventricular tachycardia has already been proved
s an electric substrate and an indicator of high mortality in patients
ith LV dysfunction (2). Second, there is no information on the use
f antiarrhythmic drugs in study patients, which might very well affect
he outcome. Third, most patients in the study (81%) underwent
evascularization by percutaneous coronary intervention, and the
uthors reported a significant increase in left ventricular ejection
raction over the initial 2 months after MI. Distal embolization is a
nown complication of percutaneous coronary intervention. Distal
mbolization is a phenomenon in which macro emboli from the
riginal lesion migrate distally, causing micro-infarcts leading to
nadequate flow at the tissue level despite reopened epicardial coronary
rtery. It is related to reduced myocardial reperfusion and a poor
rognosis (3), but the authors did not report any data about it. These
icro-infarcts could be playing a role in some of the unexplained
ncrease in mortality in post-MI patients, even though the left
entricular ejection fraction is improved significantly. There is a need
o assess the effect of these confounding variables, to truly determine
hemost accurate and clinically feasible noninvasive markers to predict
ong-term prognosis after MI. A study that combines clinical, elec-
rophysiological, and imaging (echocardiography and angiography)
ata to assess the long-term prognosis after MI is warranted.
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e thank Drs. Goyal and Punnam for their interest in our study (1).
he prevalence and prognostic significance of nonsustained ventric-
lar tachycardia (NSVT) was evaluated in the REFINE (Risk
stimation Following Infarction, Noninvasive Evaluation) study, but
hese data were not included, owing to space limitations. At 10 to 14
eeks after the index myocardial infarction (MI), 95 of the 322
atients (30%) had 1 or more NSVT episodes lasting at least 5 beats.
he prevalence of NSVT did not differ among patients who suffered
he primary outcome of cardiac death or nonfatal cardiac arrest (p 
.3) versus patients who did not. Also, NSVT was not associated with
significantly higher risk of the primary outcome (hazard ratio [HR]
.8, 95% confidence interval [CI] 0.8 to 3.8; p  0.1). Importantly,
he association between Holter-assessed impaired heart rate turbu-
ence plus abnormal repolarization alternans with an increased risk of
he primary outcome (HR 5.0, 95% CI 2.3 to 10.7; p  0.0001) was
ot altered when NSVT was adjusted for (HR 4.9, 95% CI 2.3 to
0.6; p  0.0001).
Antiarrhythmic drug use was uncommon in the REFINE study; 6
atients (2%) received amiodarone and 3 (1%) received sotalol.
ntiarrhythmic drug use was similar in patients who did versus did
ot suffer the primary outcome (p 0.2) and was not associated with
n increased risk of the primary outcome (HR 1.6, 95% CI 0.2 to
2.5; p 0.6). As with NSVT, the association of impaired heart rate
urbulence plus abnormal repolarization alternans with an increased
isk of the primary outcome was not altered when antiarrhythmic drug
sage was adjusted for (HR 5.4, 95% CI 2.3 to 12.6; p  0.0001).
We did not evaluate distal embolization in the REFINE study,
ecause we sought to assess markers of long-term risk. Multiple
tudies have shown that distal embolization impacts short-term 30- to
0-day risk of adverse clinical outcomes and not long-term 4-year risk
2,3). The strong association between impaired heart rate turbulence
lus abnormal repolarization alternans with an increased risk of the
rimary outcome was not altered when change in ejection fraction
ver the initial 2 months after MI, a surrogate of successful reperfu-
ion, was adjusted for (HR 5.1, 95% CI 2.2 to 11.9; p  0.0001).
In conclusion, the concerns of Drs. Goyal and Punnam do not
etract from our findings. As clearly demonstrated (1), the combina-
ion of impaired heart rate turbulence plus abnormal repolarization
lternans assessed in the nonacute post-MI period reliably predicts the
ong-term risk of serious outcomes. Thus, we believe these markers
re the right indicators.
Derek V. Exner, MD, MPH
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